XML 61 R47.htm IDEA: XBRL DOCUMENT v3.23.2
License Agreements - Lilly (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 163 Months Ended
Mar. 31, 2022
May 31, 2019
Dec. 31, 2009
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Mar. 31, 2016
License Agreements                  
Total revenues       $ 954,610 $ 911,397 $ 1,763,283 $ 1,644,632    
OLUMIANT Royalty Revenues                  
License Agreements                  
Total revenues       32,009 30,254 66,164 78,318    
Eli Lilly | OLUMIANT                  
License Agreements                  
Total revenues       0 70,000 0 70,000    
Eli Lilly | OLUMIANT Royalty Revenues | Non-US                  
License Agreements                  
Royalties payable on net sales       $ 32,000 $ 30,300 $ 66,200 $ 78,300    
Development Milestones | Eli Lilly                  
License Agreements                  
Amount recognized and received for the achievement of a predefined milestone               $ 149,000  
Development Milestones | Maximum | Eli Lilly                  
License Agreements                  
Upfront and immediate milestone payment to be received under license agreement     $ 150,000            
Regulatory Milestones | Eli Lilly                  
License Agreements                  
Amount recognized and received for the achievement of a predefined milestone               335,000  
Regulatory Milestones | Eli Lilly | GVHD                  
License Agreements                  
Milestone payment made under license agreement   $ 20,000              
Regulatory Milestones | Eli Lilly | GVHD | Europe                  
License Agreements                  
Milestone payment made under license agreement $ 20,000                
Regulatory Milestones | Maximum | Eli Lilly                  
License Agreements                  
Upfront and immediate milestone payment to be received under license agreement     365,000            
Regulatory Milestones | Maximum | Eli Lilly | GVHD                  
License Agreements                  
Additional milestone payments under the license agreement                 $ 40,000
Commercialization Milestones | Eli Lilly                  
License Agreements                  
Amount recognized and received for the achievement of a predefined milestone               $ 50,000  
Commercialization Milestones | Maximum | Eli Lilly                  
License Agreements                  
Upfront and immediate milestone payment to be received under license agreement     $ 150,000